Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gland Pharma
Hyderabad, Telangana, India
- Ownership
- Private
- Employees
- ~4000
- Development stage
- Other
01
Overview
Gland Pharma boasts over 70 active products with consistent growth in generics, biosimilars, and complex injectables. The company maintains high standards, with multiple regulatory approvals from US FDA, EMA, and other regulatory agencies, and demonstrates strong financial performance (FY2023 revenue INR 3,500 crore, net profit INR 700 crore). Recent US FDA approvals include Edaravone (ALS) and Cetrorelix acetate for injection.
- Therapeutic areas
- RheumatologyOphthalmologyInfectious DiseasesCardiovascularOtherOncologyNeurologyWomen's Health
- Modalities
- Small moleculePeptideHormoneBiologic
- Industry
- Biotech
02
Partnerships
Vetter PharmaKKR
Beyond the preview
Go deeper on Gland Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gland Pharma.